Use of the Impella 2.5 system alone, after and in combination with an intra-aortic balloon pump in patients with cardiogenic shock: Case description and review of the literature

EuroIntervention

Volumn 7, Issue 12, 2012, Pages 1453-1460

  Cubeddu, Roberto J ^a   Lago, Rodrigo ^b   Horvath, Sofia A ^a   Vignola, Paul A ^a   O'Neill, William ^c   Palacios, Igor F ^b  

^a Aventura Hospital and Medical Center   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF MIAMI   (United States)

Author keywords

Angiography; Angioplasty; Coronary flow

Indexed keywords

NORADRENALIN; PHENYLEPHRINE;

ADULT; ANGIOCARDIOGRAPHY; AORTA BALLOON; ASSISTED CIRCULATION; BARE METAL STENT; CARDIOGENIC SHOCK; CASE REPORT; CLINICAL FEATURE; CORONARY ARTERY BLOOD FLOW; DISEASE ASSOCIATION; DISEASE RESISTANCE; FLOW RATE; HEART ASSIST DEVICE; HEART CATHETERIZATION; HEART HEMODYNAMICS; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE FIBRILLATION; HUMAN; INTERMETHOD COMPARISON; MALE; MEDICAL HISTORY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRESSURE MEASUREMENT; RECURRENT DISEASE; REVIEW; THERAPY EFFECT; TREATMENT PLANNING;

HEART-ASSIST DEVICES; HUMANS; INTRA-AORTIC BALLOON PUMPING; MALE; MIDDLE AGED; SHOCK, CARDIOGENIC;

EID: 84860744318     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV7I12A226     Document Type: Review

References (44)

1. Fincke R, Hochman JS, Lowe AM, Menon V, Slater JN, Webb JG, LeJemtel TH, Cotter G, for the SHOCK Investigators. Cardiac power is the strongest hemodynamic correlate of mortality. J Am Coll Cardiol. 2004;44:340-348.
2. Goldberg RJ, Gore JM, Alpert JS, Osganian V, de Groot J, Bade J, Chen Z, Frid D, Dalen JE. Cardiogenic shock after acute myocardial infarction-incidence and mortality from a community wide perspective 1975-1988. N Engl J Med. 1991;325:1117-22.
3. Holmes DR Jr, Bates ER, Kleiman NS, Sadowski Z, Horgan JH, Morris DC, Califf RM, Berger PB, Topol EJ. Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. J Am Coll Cardiol. 1995;26:668-74.
4. Goldberg RJ, Samad, NA, Yarzebski J, Gurwitz J, Bigelow C, Gore JM. Temporal trends in cardiogenic shock complicating acute myocardial infarction. N Engl J Med. 1999;340:1162-1168. (Pubitemid 29177875)
5. Kantrowitz A, Tjonneland S, Freed PS, Phillips SJ, Butner AN, Sherman JL Jr. Initial clinical experience with intraaortic balloon pumping in cardiogenic shock. JAMA. 1968;203: 113-18.
6. Dormandy JA, Goetz RH, Kripke DC. Hemodynamics and coronary blood flow with counterpulsation. Surgery. 1969;65: 311-20.
7. Moulopoulos SD, Topaz S, Kolff WJ. Diastolic balloon pumping (with carbon dioxide) in the aorta - a mechanical assistance to the failing circulation. Am Heart J. 1962;63:669-75.
8. Kahn JK, Rutherford BD, McConahay DR, Johnson WL, Giorgi LV, Hartzler GO. Supported high-risk coronary angioplasty using intraaortic balloon pump counterpulsation. J Am Coll Cardiol. 1990;15:1151-5. (Pubitemid 20104578)
9. Bregman D, Casarella WJ. Percutaneous intraaortic balloon pumping: Initial clinical experiences. Ann Thorac Surg. 1980;29:153-5. (Pubitemid 10147924)
10. Remmelink M, Sjauw KD, Henriques JP, de Winter RJ, Vis MM, Koch KT, Paulus WJ, de Mol BA, Tijssen JG, Piek JJ, Baan J Jr. Effects of mechanical left ventricular unloading by Impella on left ventricular dynamics in high-risk and primary percutaneous coronary intervention patients. Catheter Cardiovasc Interv. 2010;75:187-94.
11. Henriques JP, Remmelink M, Baan J Jr, van der Schaaf RJ, Vis MM, Koch KT, Scholten EW, de Mol AJ, Tijssen JG, Piek JJ, de Winter RJ. Safety and feasibility of elective high-risk percutaneous coronary intervention procedures with left ventricular support of the Impella Recover LP 2.5. Am J Cardiol. 2006;97:990-2.
12. Sjauw KD, Konorza T, Erbel R, Danna PL, Viecca M, Minden H, Butter C, Engstrøm T, Hassager C, Machado FP, Pedrazzini G, Wagner DR, Schamberger R, Kerber S, Mathey DG, Schofer J, Engström AE, Henriques JP. Supported high-risk percutaneous coronary intervention with the Impella 2.5 device the Europella registry. J Am Coll Cardiol. 2009;54:2430-4.
13. Dixon SR, Henriques JP, Mauri L, Sjauw K, Civitello A, Kar B, Loyalka P, Resnic FS, Teirstein P, Makkar R, Palacios IF, Collins M, Moses J, Benali K, O'Neill W. A Prospective Feasibility Trial Investigating the Use of the Impella 2.5 System in Patients Undergoing High-Risk Percutaneous Coronary Intervention (The PROTECT I Trial): Initial U.S. Experience. J Am Coll Cardiol Intv. 2009;2:91-96.
14. Sjauw KD, Remmelink M, Baan J Jr, Lam K, Engström AE, van der Schaaf RJ, Vis MM, Koch KT, van Straalen JP, Tijssen JG, de Mol BA, de Winter RJ, Piek JJ, Henriques JP. Left ventricular unloading in acute STEMI patients is safe and feasible and provides acute and sustained left ventricular recovery. The AMC MACH 2 study. J Am Coll Cardiol. 2008; 51:1044-1046. (Pubitemid 351318126)
15. Colombo T, Garatti A, Bruschi G, Lanfranconi M, Russo C, Milazzo F, Catena E, Frigerio M, Vitali E. First successful bridge to recovery with the impella Recover 100 left ventricular assist device for fulminant acute myocarditis. Ital Heart J. 2003;4:642-645.
16. Meyns B, Dens J, Sergeant P, Herijgers P, Daenen W, Flameng W. Initial experiences with the Impella device in patients with cardiogenic shock - Impella support for cardiogenic shock. Thorac Cardiovasc Surg. 2003;51:312-317. (Pubitemid 38031386)
17. Mueller H, Ayres SM, Conklin EF, Giannelli S Jr, Mazzara JT, Grace WT, Nealon TF Jr. The effects of intra-aortic counterpulsation on cardiac performance and metabolism in shock associated with acute myocardial infarction. J Clin Invest. 1971;50:1885.
18. Kern MJ, Aguirre FV, Tatineni S, Penick D, Serota H, Donohue T, Walter K. Enhanced coronary blood flow velocity during intraaortic balloon counterpulsation in critically ill patients. J Am Coll Cardiol. 1993;21:359-68. (Pubitemid 23047918)
19. Scheidt S, Wilner G, Mueller H, Summers D, Lesch M, Wolff G, Krakauer J, Rubenfire M, Fleming P, Noon G, Oldham N, Killip T, Kantrowitz A. Intra-Aortic Balloon Counterpulsation in Cardiogenic Shock - Report of a Cooperative Clinical Trial. N Engl J Med. 1973;288:979-84.
20. Kern MJ, Aguirre F, Bach R, Donohue T, Siegel R, Segal J. Augmentation of coronary blood flow by intra-aortic balloon pumping in patients after coronary angioplasty. Circulation. 1993;87:500-11. (Pubitemid 23040920)
21. Urschel CW, Eber L, Forrester J, Matloff J, Carpenter R, Sonnenblick E. Alteration of mechanical performance of the ventricle by intraaortic balloon counterpulsation. Am J Cardiol. 1970;25:546-51.
22. Ishihara M, Sato H, Tateishi H, Uchida T, Dote K. Intraaortic balloon pumping as the postangioplasty strategy in acute myocardial infarction. Am Heart J. 1991;122:385-9.
23. Flaherty JT, Becker LC, Weiss JL, Brinker JA, Bulkley BH, Gerstenblith G, Kallman CH, Weisfeldt ML. Results of a randomized prospective trial of intraaortic balloon counterpulsation and intravenous nitroglycerin in patients with acute myocardial infarction. J Am Coll Cardiol. 1985;6:434-46. (Pubitemid 15048823)
24. Stone GW, Marsalese D, Brodie BR, Griffin JJ, Donohue B, Costantini C, Balestrini C, Wharton T, Esente P, Spain M, Moses J, Nobuyoshi M, Ayres M, Jones D, Mason D, Grines L, O'Neill WW, Grines CL. A prospective, randomized evaluation of prophylactic intraaortic balloon counterpulsation in high risk patients with acute myocardial infarction treated with primary angioplasty. Second Primary Angioplasty in Myocardial Infarction (PAMI-II) Trial Investigators. J Am Coll Cardiol. 1997;29:1459-67. (Pubitemid 27272437)
25. Brodie BR, Stuckey TD, Hansen C, Muncy D. Intra-aortic balloon counterpulsation before primary percutaneous transluminal coronary angioplasty reduces catheterization laboratory events in high-risk patients with acute myocardial infarction. Am J Cardiol. 1999;84:18-23. (Pubitemid 29307635)
26. Mishra S, Chu WW, Torguson R, Wolfram R, Deible R, Suddath WO, Pichard AD, Satler LF, Kent KM, Waksman R. Role of prophylactic intra-aortic balloon pump in high-risk patients undergoing percutaneous coronary intervention. Am J Cardiol. 2006;98:608-12. (Pubitemid 44233455)
27. Lincoff AM, Popma JJ, Ellis SG, Vogel RA, Topol EJ. Percutaneous support devices for high risk or complicated coronary angioplasty. J Am Coll Cardiol. 1991;17:770-80.
28. Antman EM, Hand M, Armstrong PW, Bates ER, Green LA, Halasyamani LK, Hochman JS, Krumholz HM, Lamas GA, Mullany CJ, Pearle DL, Sloan MA, Smith SC Jr; 2004 Writing Committee Members, Anbe DT, Kushner FG, Ornato JP, Jacobs AK, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Halperin JL, Hunt SA, Lytle BW, Nishimura R, Page RL, Riegel B, Tarkington LG, Yancy CW. 2007 focused update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction). Circulation. 2008;117:296-329
29. Remmelink M, Sjauw KD, Henriques JP, de Winter RJ, Koch KT, van der Schaaf RJ, Vis MM, Tijssen JG, Piek JJ, Baan J Jr. Effects of left ventricular unloading by Impella Recover LP2.5 on coronary hemodynamics. Cathet Cardiovasc Interv. 2007;70:532-537. (Pubitemid 47597025)
30. Aqel RA, Hage FG, Iskandrian AE. Improvement of myocardial perfusion with a percutaneously inserted left ventricular assist device. J Nucl Cardiol. 2010;17:158-60.
31. Valgimigli M, Steendijk P, Sianos G, Onderwater E, Serruys PW. Left ventricular unloading and concomitant total cardiac output increase by the use of percutaneous Impella Recover LP 2.5 assist device during high-risk coronary intervention. Cathet Cardiovasc Interv. 2005;65:263-267. (Pubitemid 40791523)
32. Meyns B, Stolinski J, Leunens V, Verbeken E, Flameng W. Left ventricular support by catheter-mounted axial flow pump reduces infarct size. J Am Coll Cardiol. 2003;41:1087-1095. (Pubitemid 36384893)
33. Reesink KD, Dekker AL, Van Ommen V, Soemers C, Geskes GG, van der Veen FH, Maessen JG. Miniature intracardiac assist device provides more effective cardiac unloading and circulatory support during severe left heart failure than intraaortic balloon pumping. Chest. 2004;126:896-902. (Pubitemid 39258047)
34. Tuseth V, Pettersen RJ, Grong K, Wentzel-Larsen T, Haaverstad R, Fanneløp T, Nordrehaug JE. Randomised comparison of percutaneous left ventricular assist device with open-chest cardiac massage and with surgical assist device during ischaemic cardiac arrest. Resuscitation. 2010;81:1566-70.
35. Bautista-Hernández V, Gutiérrez F, Pinar E, Gimeno JR, Arribas JM, García-Puente J, Ray VG, Arcas R, Valdés M. Initial experience with the Impella left ventricular assist device for postcardiotomy cardiogenic shock and unprotected left coronary artery angioplasty in patients with a low left ventricular ejection fraction. Rev Esp Cardiol. 2007;60:984-987. (Pubitemid 350305893)
36. Burzotta F, Paloscia L, Trani C, Mascellanti M, Mongiardo R, Materazzo G, Niccoli G, Di Marco M, Leone AM, Porto I, Mazzari MA, Rebuzzi AG, Schiavoni G, Crea F. Feasibility and long-term safety of elective Impella-assisted high-risk percutaneous coronary intervention: a pilot two-centre study. J Cardiovasc Med. 2008;9:1004-1010.
37. Abiomed, Inc. (2009). Abiomed Presents Results From Two Studies: USpella and MACH II [Press release]. Retrieved from http://www.cathlabdigest.com/ Abiomed-Presents-Results-From-Two-Studies-USpella-and-MACH-II.
38. Rossiter-Thornton M, Arun V, Forrest AP, Bayfield MS, Wilson MK. Left Ventricular Support with the Impella® LP 5.0 for Cardiogenic Shock Following Cardiac Surgery. Heart Lung Circ. 2008;17:243-5.
39. Londoño JC, Martinez CA, Singh V, O'Neill WW. Hemodynamic support with Impella 2.5 during balloon aortic valvuloplasty in a high-risk patient. J Interv Cardiol. 2011;24:193-7.
40. Seyfarth M, Sibbing D, Bauer I, Fröhlich G, Bott-Flügel L, Byrne R, Dirschinger J, Kastrati A, Schömig A. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol. 2008;52:1584-1588.
41. O'Neill WW from Abiomed, Inc. (2010). Abiomed's USpella Results Presented at EuroPCR [Press release]. Retrieved from http://bmctoday.net/citoday/2010/04/ article.asp?f=abiomeds-uspella-results-presented-at-europcr.
42. Sauren LD, Accord RE, Hamzeh K, de Jong M, van der Nagel T, van der Veen FH, Maessen JG. Combined Impella and intraaortic balloon pump support to improve both ventricular unloading and coronary blood flow for myocardial recovery: an experimental study. Artif Organs. 2007;31:839-42. (Pubitemid 350131996)
43. Jung C, Ferrari M, Rödiger C, Fritzenwanger M, Figulla HR. Combined Impella and intra-aortic balloon pump support to improve macro- and microcirculation: a clinical case. Clin Res Cardiol. 2008;97:849-50.
44. Gupta A, Allaqaband S, Bajwa T. Combined use of impella device and intra-aortic balloon pump to improve survival in a patient in profound cardiogenic shock post cardiac arrest. Catheter Cardiovasc Interv. 2009;74:975-6.